Retatrutide 5mg+ cagrilintide 5mg 10mg × 10
Research-use disclaimer
All products are strictly for laboratory research and in-vitro studies, not for human consumption.
Description
Combination peptide formulation for fat loss, synergistically promoting fat metabolism and weight control through dual targeting mechanism.
Effects
Enhances basal metabolic rate; Suppresses appetite and delays gastric emptying; Improves insulin sensitivity; Accelerates lipolysis; Reduces visceral fat accumulation; Improves blood glucose control.
Usage
Subcutaneous injection once weekly; start with low dose and gradually increase; specific dosage as per physician's instructions; typical cycle of 12-24 weeks.
Suitable for
Overweight or obese individuals; Those with weight loss needs accompanied by metabolic syndrome; Patients with type 2 diabetes and obesity.
Not suitable for
Individuals allergic to any of the ingredients; Those with a history of pancreatitis; Severe hepatic or renal impairment; Pregnant or breastfeeding women; Personal or family history of medullary thyroid carcinoma.
Ingredients
Retatrutide 5mg + Cagrilintide 5mg
Storage
Store refrigerated at 2-8°C, protect from light, do not freeze.
Shelf life
24 months
Product research FAQ
What is this product intended for?
It is supplied strictly for laboratory research and in-vitro studies, not for human consumption.
Is batch documentation available?
Available batch-specific Certificates of Analysis are listed in the COA section on this page.
How should the product be stored?
Follow the storage information shown on this page and the instructions supplied with the specific batch.
